Please assess the completion status of the following clinical trial:

Trial Title: Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing PCI/angiography~* No previously known side effects of statins~* Patients who sign an informed consent~* Age \> 18 years old~Exclusion Criteria:~* Patients with ST elevation myocardial infarction~* Patients with cardiogenic shock~* Patients with hypersensitivity to statins~* Patients with unexplained muscle pain~* Patients with acute liver disease~* Patients receiving cyclosporine, antifungal azoles, macrolide antibiotics, niacin, fibrates\> 1 quart grapefruit juice/day or nefazodone~* Patients with creatinine \> 2.0~* Patients with known malignancy~* Ejection Fraction \< 25%~* No coronary care unit patients~* No outpatients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Simvastatin (Type: ACTIVE_COMPARATOR): Subjects randomized to this arm will be pretreated with 80 mg (2 pills) simvastatin approximately one hour prior to percutaneous coronary intervention.
- Placebo (Type: PLACEBO_COMPARATOR): Subjects randomized to this arm will be pretreated with 2 placebo pills approximately one hour prior to percutaneous coronary intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).